• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

冷漠在体重管理项目效果中的作用。

Role of apathy in the effectiveness of weight management programmes.

机构信息

Omaha VA Medical Center, Omaha, NE, USA.

出版信息

Diabetes Obes Metab. 2012 May;14(5):419-23. doi: 10.1111/j.1463-1326.2011.01544.x. Epub 2011 Dec 28.

DOI:10.1111/j.1463-1326.2011.01544.x
PMID:22145671
Abstract

AIMS

Obesity, which is at epidemic proportions in the USA, is associated with a higher risk of several co-morbid diseases including, cardiovascular disease, cancer and sleep apnea. Weight loss and weight maintenance programmmes are difficult to sustain for long term. Mental health problems such as apathy may be a major factor in patients unsuccessful in adhering to weight loss programmes. We propose that treating apathy will result in better weight loss in obese patients.

METHODS

This was a randomized prospective pilot study. Obese patients (n = 101) were randomized in a 1:2:2 ratio to either (i) standard nutrition counselling; or (ii) the Department of Veterans Affairs weight loss programme called 'motivate obese veterans everywhere ' (MOVE); or (iii) methylphenidate treatment plus the MOVE programme together. The intervention was for 6 months (26 weeks).

RESULTS

For the within groups analysis, the absolute changes in weight (kg) are as follows, for MOVE (mean: -1.84; 95% confidence interval (CI): -4.56 to 0.87; p = 0.25), Methylphenidate (mean: -4.61; 95% CI: -7.90 to -1.33; p = 0.04), standard nutrition counselling (mean: -0.60; 95% CI: -2.59 to 1.39; p = 0.21), which indicates that although all three groups lost weight, only the methylphenidate group achieved statistical significance. The between group differences of the relative change in weight were not statistically different. The apathy evaluation score and the patient activation measure improved in all groups.

CONCLUSION

Together these data suggest that treating apathy might be an important factor in the success of weight management programmes.

摘要

目的

肥胖在美国已呈流行趋势,与多种合并疾病的风险增加相关,包括心血管疾病、癌症和睡眠呼吸暂停。减肥和体重维持计划很难长期维持。冷漠等心理健康问题可能是患者无法坚持减肥计划的一个主要因素。我们提出,治疗冷漠将导致肥胖患者更好的减肥效果。

方法

这是一项随机前瞻性试点研究。肥胖患者(n = 101)按 1:2:2 的比例随机分为三组:(i)标准营养咨询;(ii)退伍军人事务部的减肥计划,称为“激励肥胖退伍军人无处不在”(MOVE);或(iii)哌醋甲酯治疗加 MOVE 计划。干预持续 6 个月(26 周)。

结果

对于组内分析,体重(kg)的绝对变化如下,MOVE 组(均值:-1.84;95%置信区间(CI):-4.56 至 0.87;p = 0.25),哌醋甲酯组(均值:-4.61;95% CI:-7.90 至-1.33;p = 0.04),标准营养咨询组(均值:-0.60;95% CI:-2.59 至 1.39;p = 0.21),这表明尽管所有三组都减轻了体重,但只有哌醋甲酯组达到了统计学意义。体重相对变化的组间差异无统计学意义。所有组的冷漠评估评分和患者激活测量都有所改善。

结论

这些数据表明,治疗冷漠可能是体重管理计划成功的一个重要因素。

相似文献

1
Role of apathy in the effectiveness of weight management programmes.冷漠在体重管理项目效果中的作用。
Diabetes Obes Metab. 2012 May;14(5):419-23. doi: 10.1111/j.1463-1326.2011.01544.x. Epub 2011 Dec 28.
2
Small-changes obesity treatment among veterans: 12-month outcomes.退伍军人的小改变肥胖治疗:12个月的结果。
Am J Prev Med. 2014 Nov;47(5):541-53. doi: 10.1016/j.amepre.2014.06.016. Epub 2014 Sep 10.
3
Methylphenidate for the treatment of apathy in Alzheimer disease: prediction of response using dextroamphetamine challenge.用于治疗阿尔茨海默病淡漠症状的哌醋甲酯:利用右旋苯丙胺激发试验预测疗效
J Clin Psychopharmacol. 2008 Jun;28(3):296-301. doi: 10.1097/JCP.0b013e318172b479.
4
Adverse effects of methylphenidate for apathy in patients with Alzheimer's disease (ADMET2 trial).阿得拉(ADMET2 试验):用于治疗阿尔茨海默病患者淡漠症状的哌醋甲酯的不良反应。
Int J Geriatr Psychiatry. 2024 Jun;39(6):e6108. doi: 10.1002/gps.6108.
5
Methylphenidate may treat apathy independent of depression.
Ann Pharmacother. 2005 Nov;39(11):1947-9. doi: 10.1345/aph.1G352. Epub 2005 Oct 4.
6
Transition from methylphenidate or amphetamine to atomoxetine in children and adolescents with attention-deficit/hyperactivity disorder--a preliminary tolerability and efficacy study.注意缺陷多动障碍儿童及青少年从哌甲酯或苯丙胺转换为托莫西汀的初步耐受性和疗效研究
Clin Ther. 2007 Jun;29(6):1168-77. doi: 10.1016/j.clinthera.2007.06.017.
7
X-PERT: weight reduction with orlistat in obese subjects receiving a mildly or moderately reduced-energy diet: early response to treatment predicts weight maintenance.X-PERT研究:接受轻度或中度能量减少饮食的肥胖受试者使用奥利司他减重:治疗早期反应可预测体重维持情况
Diabetes Obes Metab. 2005 Nov;7(6):699-708. doi: 10.1111/j.1463-1326.2005.00483.x.
8
The Apathy in Dementia Methylphenidate Trial 2 (ADMET 2): study protocol for a randomized controlled trial.《痴呆症哌醋甲酯试验 2 中的淡漠(ADMET 2):一项随机对照试验研究方案》。
Trials. 2018 Jan 18;19(1):46. doi: 10.1186/s13063-017-2406-5.
9
Effect of Methylphenidate on Apathy in Patients With Alzheimer Disease: The ADMET 2 Randomized Clinical Trial.**标题**:哌醋甲酯治疗阿尔茨海默病患者淡漠症状的效果:ADMET-2 随机临床试验 **摘要**: **背景**:淡漠是阿尔茨海默病患者常见的非认知症状之一,可能会导致认知和功能下降,以及生活质量降低。 **目的**:评估哌醋甲酯对阿尔茨海默病患者淡漠症状的疗效。 **设计、地点和参与者**:ADMET-2 是一项双盲、安慰剂对照、随机临床试验,在加拿大和美国的 14 个记忆和老龄化诊所进行。招募了年龄在 55 岁及以上、有轻度至中度阿尔茨海默病、基线时淡漠症状严重且稳定的患者。患者被随机分配(1∶1)接受哌醋甲酯或安慰剂治疗,每天 2 次,持续 12 周。主要结局是从基线到第 12 周时,经过验证的淡漠症状量表(斯坦福嗜睡量表)的变化。 **干预**:哌醋甲酯(10 至 40 mg)或安慰剂。 **结果**:共 147 名患者被随机分配接受哌醋甲酯(n=73)或安慰剂(n=74)治疗。两组患者的基线特征相似。在第 12 周时,哌醋甲酯组患者的淡漠症状显著改善(平均差异,-4.66 点;95% CI,-7.73 点至-1.59 点;P=0.002),而安慰剂组患者的淡漠症状无显著变化(平均差异,-0.77 点;95% CI,-3.34 点至1.79 点;P=0.55)。哌醋甲酯组和安慰剂组患者的不良事件发生率相似(28.8%比 24.3%;P=0.72)。 **结论和意义**:在这项为期 12 周的临床试验中,与安慰剂相比,哌醋甲酯治疗可显著改善阿尔茨海默病患者的淡漠症状,且安全性和耐受性良好。这些结果支持在阿尔茨海默病患者中进一步研究哌醋甲酯治疗淡漠症状的作用。 **临床试验注册**:ClinicalTrials.gov 注册号:NCT01275076。
JAMA Neurol. 2021 Nov 1;78(11):1324-1332. doi: 10.1001/jamaneurol.2021.3356.
10
Counselling overweight and obese patients in primary care: a prospective cohort study.基层医疗中对超重和肥胖患者的咨询:一项前瞻性队列研究。
Eur J Cardiovasc Prev Rehabil. 2006 Apr;13(2):222-8. doi: 10.1097/01.hjr.0000209819.13196.a4.

引用本文的文献

1
Is Sigstad's score really capable of detecting post-surgical late dumping syndrome?西格斯塔德评分真的能检测出术后迟发性倾倒综合征吗?
Langenbecks Arch Surg. 2024 Mar 12;409(1):94. doi: 10.1007/s00423-024-03283-2.
2
Opportunity cost determines free-operant action initiation latency and predicts apathy.机会成本决定自由操作行为启动潜伏期,并可预测冷漠。
Psychol Med. 2023 Apr;53(5):1850-1859. doi: 10.1017/S0033291721003469. Epub 2021 Oct 12.
3
Interdialytic weight gain is not associated with symptoms of depression or apathy in patients on chronic hemodialysis.
透析间期体重增加与慢性血液透析患者的抑郁或冷漠症状无关。
Int Urol Nephrol. 2023 Jun;55(6):1589-1595. doi: 10.1007/s11255-023-03473-9. Epub 2023 Jan 23.
4
Behavioral Symptomatology in the Premenstruum.经前期的行为症状学
Brain Sci. 2022 Jun 22;12(7):814. doi: 10.3390/brainsci12070814.
5
Scope of Use and Effectiveness of Dietary Interventions for Improving Health-Related Outcomes in Veterans: A Systematic Review.膳食干预改善退伍军人健康相关结局的使用范围和效果:系统评价。
Nutrients. 2022 May 17;14(10):2094. doi: 10.3390/nu14102094.
6
A review of psychosocial factors and personality in the treatment of obstructive sleep apnoea.阻塞性睡眠呼吸暂停治疗中的心理社会因素和人格研究综述。
Eur Respir Rev. 2019 Jun 26;28(152). doi: 10.1183/16000617.0005-2019. Print 2019 Jun 30.
7
Global Performance of Executive Function Is Predictor of Risk of Frailty and Disability in Older Adults.执行功能的整体表现是老年人虚弱和残疾风险的预测指标。
J Nutr Health Aging. 2017;21(9):980-987. doi: 10.1007/s12603-017-0895-2.
8
Do Psychological Factors Help to Reduce Body Mass in Obesity or is it Vice Versa? Selected Psychological Aspects and Effectiveness of the Weight-Loss Program in the Obese Patients.心理因素有助于减轻肥胖者的体重吗?还是恰恰相反?肥胖患者减肥计划的特定心理因素及效果
Health Psychol Res. 2013 Mar 21;1(1):e10. doi: 10.4081/hpr.2013.e10. eCollection 2013 Jan 2.
9
Patient Activation is Inconsistently Associated with Positive Health Behaviors Among Obese Safety Net Patients.在肥胖的安全网患者中,患者激活与积极的健康行为之间的关联并不一致。
J Immigr Minor Health. 2016 Dec;18(6):1489-1497. doi: 10.1007/s10903-015-0285-y.
10
Piloting a new approach to the treatment of obesity using dexamphetamine.试用右旋苯丙胺治疗肥胖症的新方法。
Front Endocrinol (Lausanne). 2015 Feb 9;6:14. doi: 10.3389/fendo.2015.00014. eCollection 2015.